The Role of Laser and Energy-Assisted Drug Delivery in the Treatment of Alopecia

    February 2024 in “ Lasers in Medical Science
    Eliza Balazic, Ahava Muskat, Yana Kost, Joel L. Cohen, Kseniya Kobets
    From the encyclopedia
    Alopecia Areata →

    autoimmune disorder causing patchy hair loss

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Microneedling →

    technique to create small wounds in skin to activate collagen production and hair growth

    Image
    Studysummary This review discusses laser and energy-assisted drug delivery as a treatment for alopecia and concludes that although all studies show positive effects, some reports indicate no superiority over existing monotherapies. Our plain-language summary of this paper — not a Tressless recommendation.
    The review evaluates the use of laser and energy-assisted drug delivery (LEADD) in treating alopecia, specifically alopecia areata (AA) and androgenetic alopecia (AGA)/pattern hair loss (PHL). The strongest evidence for LEADD in alopecia treatment involves the use of ablative fractional lasers (AFL) with topical corticosteroids. Minoxidil, combined with all devices (AFL, non-ablative lasers (NAFL), and radiofrequency microneedling (RFNM)), showed a positive effect. However, the superiority of LEADD over monotherapy or microneedling is not consistently proven. All studies showed improvement in alopecia, suggesting that laser monotherapy could be an effective treatment for hair growth. The review concludes that LEADD is a rapidly emerging treatment modality for AGA and AA, but larger, well-designed studies are needed for more definitive conclusions.
    Discuss this study in the Community →

    Research cited in this study

    15 / 15 results